The health policy landscape in Washington continues to move quickly as the Trump administration expands its Make America Healthy Again agenda, states sharpen their focus on maternal health and affordability, and regulators confront new questions around AI, precision medicine, and mental health treatment. This week’s developments highlight the growing intersection between politics, public health, and the life sciences industry. From RFK Jr.’s evolving health priorities to bipartisan state initiatives and FDA scrutiny of emerging therapies, stakeholders across the health sector are navigating a rapidly shifting environment. Below is a breakdown of the biggest federal, state, and industry stories shaping the conversation this week.

In this week’s Nimitz Health:

• Federal News

  • MAHA movement and voter sentiment, RFK Jr.’s antidepressant scrutiny, Moms.gov launch and maternal health initiatives, and ARPA-H AI research investments

• State News

  • Alaska Senate race and health care affordability, Governors Wes Moore and Sarah Huckabee Sanders on maternal health

• Industry News

  • FDA skepticism of ctDNA breast cancer strategy, AI-driven biomedical research initiatives, public health response to hantavirus concerns

WHO’S HAVING EVENTS THIS WEEK?

Wednesday, May 13th

• *Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Subcommittee: “Hearings to examine the President's Fiscal Year 2027 Budget Request for the United States Food and Drug Administration” at 10:30 am. Watch here.

*Will be covered by Nimitz Health. Please email [email protected] if you would like a readout of any other hearings.

Sign up for The Nimitz Report for Veteran Health-Related Hearings

NEWS DRIVING THE WEEK

Federal News

Washington’s health agenda continues to be shaped by the Trump administration’s Make America Healthy Again push. HHS launched Moms.gov on Mother’s Day as a new federal resource for new and expecting mothers, with information on pregnancy centers, FQHCs, nutrition, breastfeeding, mental health, adoption, preconception health, Trump Accounts, and Trump Rx. The launch comes as the administration tries to frame maternal and family health as part of its broader prevention-first agenda.

Secretary Kennedy took that message on the road in Ohio, where he met with leaders from Cleveland Clinic, University Hospitals, MetroHealth, and Summa Health, while also visiting a Head Start program, a regenerative farm, and an addiction recovery facility. HHS used the trip to emphasize nutrition, chronic disease prevention, addiction recovery, and AI-enabled preventive care, including a $30,000 nutrition grant to a Toledo Head Start provider.

Secretary Kennedy also escalated scrutiny of antidepressant prescribing practices, arguing in recent interviews and public appearances that the country has become “overmedicalized,” particularly around psychiatric medications and SSRIs. Kennedy has suggested HHS should more aggressively examine long-term antidepressant use and potential overprescribing, drawing criticism from mental health advocates and medical societies that warn the rhetoric could stigmatize treatment for depression and anxiety at a time when behavioral health needs remain elevated nationwide. The debate is becoming one of the clearest fault lines within the administration’s broader MAHA agenda, as officials push for greater focus on lifestyle and prevention while providers caution against undermining evidence-based mental health care.

MAHA’s political resonance is broad but not unlimited. A new KFF poll found 41 percent of adults say they support the movement, and large majorities are concerned about food additives, pesticides, and corporate influence. But health care costs remain voters’ dominant health priority, including among MAHA supporters, where 42 percent said lowering costs should be the federal government’s top health priority.

The administration is also still working through public health leadership turbulence. President Trump withdrew Casey Means’ stalled surgeon general nomination and moved to nominate radiologist Nicole Saphier instead, after Means faced Senate concerns over her credentials and vaccine views.

State News

Alaska is emerging as an early test case for how health care affordability could shape the 2026 Senate map. Senator Dan Sullivan is facing a challenge from former Rep. Mary Peltola, and outside groups are already focusing on health care costs, ACA coverage, and affordability as central campaign issues.

Maryland Governor Wes Moore and Arkansas Governor Sarah Huckabee Sanders also drew attention this week for highlighting bipartisan maternal health investments despite their broader political differences. The governors emphasized expanding prenatal and postpartum care access, improving maternal outcomes and addressing the nation’s persistently high maternal mortality rate, underscoring how maternal health continues to be one of the few areas generating cross-party momentum among governors ahead of the 2026 election cycle.

Industry News

The FDA’s Oncologic Drugs Advisory Committee dealt a setback to AstraZeneca’s camizestrant strategy in metastatic breast cancer, voting 6-3 that the SERENA-6 trial had not demonstrated a clinically meaningful benefit for switching therapy based on circulating tumor DNA detection before radiographic progression. The vote does not bind FDA, but it signals continued agency caution around ctDNA-driven treatment changes in metastatic disease.

Separately, ARPA-H launched its five-year Intelligent Generator of Research program, or IGoR, to build an AI-enabled research ecosystem aimed at accelerating biomedical discovery and improving reproducibility. The program will fund teams working across computational biology, AI, experimental science, and lab infrastructure, with an emphasis on complex chronic diseases such as Alzheimer’s, Parkinson’s, lupus, and autoimmune conditions.

Finally, public health officials are working to keep hantavirus concerns in perspective after a cruise ship outbreak drew national attention. ECDC reported nine total cases tied to the MV Hondius as of May 11, including three deaths, but said the risk to the general population is very low.

FOR FUN

The Washington Wizards landed the No. 1 pick in the 2026 NBA Draft Lottery yesterday. Take a look at their No. 1 picks of the past!

JOIN THE NIMITZ NETWORK!

Enjoying our updates? Don’t keep it to yourself — forward this email to friends or colleagues who’d love to stay informed. Please subscribe to our other publications by clicking below: